Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant
Author(s) -
Anne Bergeron,
Sylvie Chevret,
Angéla Granata,
Patrice Chevallier,
Laure Vincent,
Anne Huynh,
Reza Tabrizi,
Hélène LabussièreWallet,
Marc Bernard,
Sylvain Chantepie,
JacquesOlivier Bay,
Anne ThiebautBertrand,
Sylvain Thépot,
Nathalie Contentin,
LucMatthieu Fornecker,
Natacha Maillard,
Karine Risso,
Ana Berceanu,
Didier Blaise,
Régis Peffault de la Tour,
Jason W. Chien,
Valérie Coiteux,
Gèrard Socié
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.9938
Subject(s) - medicine , bronchiolitis obliterans , azithromycin , hematopoietic stem cell transplantation , transplantation , surgery , pediatrics , lung transplantation , microbiology and biotechnology , biology , antibiotics
Bronchiolitis obliterans syndrome has been associated with increased morbidity and mortality after allogeneic hematopoietic stem cell transplant (HSCT). Previous studies have suggested that azithromycin may reduce the incidence of post-lung transplant bronchiolitis obliterans syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom